Attributable Mortality of Nosocomial Candidemia, Revisited
The DOI matches its Crossref record; 35 of the 37 references it cites were found in a registry or an index.
Abstract
We reexamined the attributable mortality of nosocomial candidemia 15 years after a retrospective cohort study performed at our hospital demonstrated an attributable mortality of 38%. For all episodes of nosocomial candidemia between 1 July 1997 and 30 June 2001, we matched control patients with case patients by age, sex, date of hospital admission, underlying disease(s), length of time at risk, and surgical procedure(s). We analyzed 108 matched pairs. There were no statistically significant differences in age, sex, underlying disease(s), time at risk, surgical procedure, or vital signs at admission between cases and controls. The crude mortality among case patients was 61% (66 of 108 patients), compared with 12% (13 of 108) among control patients, for an attributable mortality of 49% (95% CI, 38%-60%). Nosocomial candidemia is still associated with an extremely high crude and attributable mortality--much higher than that expected from underlying disease alone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These infections are associated with attributable mortality rates that have ranged from 38% between 1983 and 1986 (46) to 49% in the same institutions between 1997 and 2001 (13).”
In the citing paper
“Attributable mortality of candidiasis was evaluated retrospectively between 1997 and 2001 in 108 matched pairs [12], the crude mortality among case patients was 61% compared with 12% in controls; the resulting ''attributable mortality'' was therefore estimated to be 49%.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [12]
In the citing paper
“Studies on patients with IC have similarly shown excessive rates of inappropriate initial therapy and even higher mortality than infections caused by bacterial pathogens in the ICU setting.10,14,33,34,[42][43][44][45][46][47]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
In the citing paper
“Numerous reports have documented the association between inadequate dosing of antifungals in patients with IC and increased length of hospital stay, health care costs, morbidity, and mortality.”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [14]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Self-citationComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Weinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Research works printed but not linked: 3
- Harvey, 1987, Archives of Internal Medicine, 147, 2117, 10.1001/archinte.1987.00370120053011 · doi:10.1001/archinte.1987.00370120053011
- Martin, 1989, Annals of Internal Medicine, 110, 9, 10.1059/0003-4819-110-1-9 · doi:10.1059/0003-4819-110-1-9
- O'Grady, 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control, 51, 1
Cited by
Items 301–400 of 1,000
Effectiveness of Anidulafungin in Eradicating Candida Species in Invasive Candidiasis
Pfaller, M. A., Diekema, D. J., Boyken, L. B., Messer, S. A., Tendolkar, S., Hollis, R. J., & Goldstein, B. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4795-4797.2005 · Cited by 66
Self-citationSimon, S. P., Li, R., Silver, M., Andrade, J., Tharian, B., Fu, L., Villanueva, D., Abascal, D. G., Mayer, A., Truong, J., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac735 · Cited by 56
Inhibitory Effect of Shikonin on Candida albicans Growth
Hao, M., Zhao, L., Li, C., Shang, Q., Lu, H., Fu, Z., Wang, L., Jiang, Y., & Cao, Y. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00338 · Cited by 65
van der Elst, K. C. M., Span, L. F. R., van Hateren, K., Vermeulen, K. M., van der Werf, T. S., Greijdanus, B., Kosterink, J. G. W., Uges, D. R. A., & Alffenaar, J. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00707-13 · Cited by 65
Lepak, A. J., Marchillo, K., VanHecker, J., Diekema, D. J., & Andes, D. R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01354-13 · Cited by 65
Self-citationChen, A., & Sobel, J. D. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.1.21 · Cited by 59
Kong, L., Yang, C., Dong, L., Diao, Q., Si, B., Ma, J., & Tu, Y. (2019) · Animals · doi:10.3390/ani9110990 · Cited by 64
Wong, S. S. W., Samaranayake, L. P., & Seneviratne, C. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.009 · Cited by 64
Low Caspofungin Exposure in Patients in Intensive Care Units
van der Elst, K. C. M., Veringa, A., Zijlstra, J. G., Beishuizen, A., Klont, R., Brummelhuis-Visser, P., Uges, D. R. A., Touw, D. J., Kosterink, J. G. W., van der Werf, T. S., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01582-16 · Cited by 64
Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis
Bar-Yosef, H., Gonzalez, N. V., Ben‐Aroya, S., Kron, S. J., & Kornitzer, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-05741-y · Cited by 64
Lee, R. A., Zurko, J. C., Camins, B. C., Griffin, R. L., Rodriguez, J. M., McCarty, T. P., Magadia, J., & Pappas, P. G. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy849 · Cited by 64
Developments in the treatment of candidiasis: more choices and new challenges
Aperis, G., Myriounis, N., Spanakis, E. K., & Mylonakis, E. E. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.11.1319 · Cited by 64
Kasai, M., Francesconi, A., Petraitienė, R., Petraitis, V., Kelaher, A. M., Kim, H.-S., Meletiadis, J., Sein, T., Bacher, J., & Walsh, T. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.1.143-150.2006 · Cited by 64
Dupont, B., Lortholary, O., Ostrosky-Zeichner, L. L., Stucker, F., & Yeldandi, V. V. (2009) · Critical Care · doi:10.1186/cc8117 · Cited by 63
Epithelial hypoxia maintains colonization resistance against Candida albicans
Savage, H. P., Bays, D. J., Tiffany, C. R., Gonzalez, M. A. F., Bejarano, E. J., de Carvalho, T. P., Luo, Z. L., Masson, H. L. P., Nguyen, H., Santos, R. L., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.05.008 · Cited by 63
Invasive Fungal Infections in the ICU
Shoham, S., & Marwaha, S. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609355262 · Cited by 63
Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62
Shorr, A. F., Gupta, V., Sun, X., Johannes, R. S., Spalding, J., & Tabak, Y. P. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a0f95d · Cited by 62
Lin, C.-Y., Chen, Y.-C., Lo, H.-J., Chen, K.-W., & Li, S.-Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00699-07 · Cited by 62
“Candida species are the most common opportunistic pathogens in debilitated or immunocompromised hosts and cause systemic candidiasis, which has high rates of morbidity and mortality (20, 21, 28, 44).”
BackgroundLuo, G., Ibrahim, A. S., French, S. W., Edwards, J. E., & Fu, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025909 · Cited by 62
“Notwithstanding current antifungal therapy [3,4,5], mortality remains unacceptably high [6,7,8].”
BackgroundWengenack, N. L., & Binnicker, M. J. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.014 · Cited by 62
Treatment of Candida Infections with Amphotericin B Lipid Complex
Ito, J. I., & Hooshmand-Rad, R. (2005) · Clinical Infectious Diseases · doi:10.1086/429330 · Cited by 62
Liposomal amphotericin B: clinical experience and perspectives
Gibbs, W. J., Drew, R. H., & Perfect, J. R. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.2.167 · Cited by 62
Leach, M. D., Tyc, K. M., Brown, A. J. P., & Klipp, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032467 · Cited by 61
Luzzati, R., Cavinato, S., Giangreco, M., Granà, G., Centonze, S., Deiana, M. L., Biolo, G., & Barbone, F. (2013) · Mycoses · doi:10.1111/myc.12090 · Cited by 61
Ruiz, L. D. S., Khouri, S., Hahn, R. C., Silva, E. G., Oliveira, V. K. P., Gandra, R. F., & Paula, C. R. (2013) · Mycopathologia · doi:10.1007/s11046-013-9616-5 · Cited by 61
Riggle, P. J., & Kumamoto, C. A. (2006) · Eukaryotic Cell · doi:10.1128/ec.00243-06 · Cited by 61
Pasqualotto, A. C., de Moraes, A. B., Zanini, R. R., & Severo, L. C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/516658 · Cited by 60
Wang, H., Liu, N., Yin, M., Han, H., Yue, J., Zhang, F., Shan, T., Guo, H., & Wu, D. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0609-x · Cited by 60
Rosseti, I. B., Chagas, L. R., & Costa, M. S. (2013) · Lasers in Medical Science · doi:10.1007/s10103-013-1473-4 · Cited by 60
Attributable mortality of candidemia after introduction of echinocandins
Cornely, F. B., Cornely, O. A., Salmanton‐García, J., Koehler, F. C., Koehler, P. A., Seifert, H., Wingen-Heimann, S. M., & Mellinghoff, S. C. (2020) · Mycoses · doi:10.1111/myc.13177 · Cited by 60
Alenazy, H., Alghamdi, A., Pinto, R. L., & Daneman, N. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.092 · Cited by 60
Reller, M. E., Mallonee, A. B., Kwiatkowski, N. P., & Merz, W. G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01127-07 · Cited by 60
Epidemiology of Community‐Onset Candidemia in Connecticut and Maryland
Sofair, A. N., Lyon, G. M., Huie‐White, S., Reiss, E., Harrison, L. H., Sanza, L. T., Arthington‐Skaggs, B. A., & Fridkin, S. K. (2006) · Clinical Infectious Diseases · doi:10.1086/504807 · Cited by 54
Velasco, E., & Bigni, R. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0546-y · Cited by 59
“The worst clinical outcome observed in adults with candidemia is in accordance with earlier reports that demonstrated significant survival differences between elderly patients and children [5, 6, 16, 20].”
ResultCandida: epidemiología y factores de riesgo para especies no albicans
Cornistein, W., Mora, A., Orellana, N., Capparelli, F. J., & Castillo, M. D. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.09.011 · Cited by 59
An Introduction to the Medically Important Candida Species
Moran, G. P., Coleman, D. C., & Sullivan, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch2 · Cited by 59
The interplay between inflammasome activation and antifungal host defense
van de Veerdonk, F. L., Joosten, L. A. B., & Netea, M. G. (2015) · Immunological Reviews · doi:10.1111/imr.12280 · Cited by 59
Chou, H.-H., Lo, H., Chen, K.-W., Liao, M.-H., & Li, S. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.03.014 · Cited by 59
Chamilos, G., Nobile, C. J., Bruno, V. M., Lewis, R. E., Mitchell, A. P., & Kontoyiannis, D. P. (2009) · The Journal of Infectious Diseases · doi:10.1086/599363 · Cited by 47
Synergy of the antibiotic colistin with echinocandin antifungals in Candida species
Zeidler, U., Bougnoux, M.-E., Lupan, A., Helynck, O., Doyen, A., Garcia, Z., Sertour, N., Clavaud, C., Munier-Lehmann, H., Saveanu, C., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks538 · Cited by 58
Wall, G., Herrera, N., & Lopez-Ribot, J. L. (2019) · Journal of Fungi · doi:10.3390/jof5040092 · Cited by 58
Xu, M., Li, L., Pan, W., Zheng, H., Wang, M.-L., Peng, X., Dai, S.-Q., Tang, Y., Zeng, K., & Huang, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.766138 · Cited by 58
van de Veerdonk, F. L., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., & Kullberg, B. J. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00232.x · Cited by 58
Candidemia: species involved, virulence factors and antimycotic susceptibility.
Luca, C. D., Guglielminetti, M. L., Ferrario, A., Calabr, M., & Casari, E. (2012) · PubMed · Cited by 58
Central venous catheter (CVC) removal for patients of all ages with candidaemia
Janum, S., & Afshari, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011195.pub2 · Cited by 58
Saville, S. P., Lazzell, A. L., Chaturvedi, A. K., Monteagudo, C. C., & Lopez-Ribot, J. L. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00480-08 · Cited by 58
Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines
Patel, M., Kunz, D. F., Trivedi, V. M., Jones, M. G., Moser, S. A., & Baddley, J. W. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.12.010 · Cited by 58
Tan, T. Y., Tee, N. W. S., & Ng, L. S. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n10p835 · Cited by 58
Fungal bloodstream infections in tertiary care hospitals in Colombia
Cortés, J. A., Reyes, P., Gómez, C., Buitrago, G., & Leal, A. L. (2011) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.12.002 · Cited by 58
Chang, W., Li, Y., Zhang, L., Cheng, A., & Lou, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041624 · Cited by 54
Glittenberg, M. T., Silas, S., MacCallum, D. M., Gow, N. A. R., & Ligoxygakis, P. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.006619 · Cited by 49
Septic Shock Due to Candidemia: Outcomes and Predictors of Shock Development
Guzmán (2011) · Journal of Clinical Medicine Research · doi:10.4021/jocmr536w · Cited by 57
Risk factors predicting Candida infective endocarditis in patients with candidemia
Foong, K. S., Sung, A., Burnham, J. P., Kronen, R., Lian, Q., Zetina, A. S., Hsueh, K., Lin, C., Powderly, W. G., & Spec, A. (2019) · Medical Mycology · doi:10.1093/mmy/myz104 · Cited by 57
Pieri, M., Agracheva, N., Fumagalli, L. A., Greco, T., Bonis, M. D., Calabrese, M. C., Rossodivita, A., Zangrillo, A., & Pappalardo, F. (2012) · Medicina Intensiva · doi:10.1016/j.medin.2012.08.009 · Cited by 57
Candida identification: a journey from conventional to molecular methods in medical mycology
Alam, M. Z., Alam, Q., Jiman-Fatani, A. A., Kamal, M. A., Abuzenadah, A. M., Chaudhary, A., Akram, M., & Haque, A. (2013) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-013-1574-z · Cited by 57
Bonfietti, L. X., Martins, M. D. A., Szeszs, M. W., Pukinskas, S. R. B. S., Purisco, S. U., Pimentel, F. C., Pereira, G. H., Silva, D. C., de Oliveira, L., & Melhem, M. D. S. C. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.037812-0 · Cited by 57
The Epidemiological Profile of Candidemia at an Indian Trauma Care Center
Tak, V., Mathur, P., Varghese, P., Gunjiyal, J., Xess, I., & Misra, M. C. (2014) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.141506 · Cited by 56
Pitman, S. K., Drew, R. H., & Perfect, J. R. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.607811 · Cited by 56
Human genetic susceptibility toCandidainfections
Plantinga, T. S., Johnson, M. D., Scott, W. K., Joosten, L. A. B., van der Meer, J. W. M., Perfect, J. R., Kullberg, B. J., & Netea, M. G. (2012) · Medical Mycology · doi:10.3109/13693786.2012.690902 · Cited by 56
Slater, J. L., Howard, S. J., Sharp, J., Goodwin, J., Gregson, L., Alastruey‐Izquierdo, A., Arendrup, M. C., Warn, P. A., Perlin, D. S., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01686-10 · Cited by 56
Harrison, D. A., Muskett, H., Harvey, S. E., Grieve, R., Shahin, J., Patel, K., Sadique, Z., Allen, E., Dybowski, R., Jit, M., et al. (2013) · Health Technology Assessment · doi:10.3310/hta17030 · Cited by 56
Park, S., Kım, K., Jang, J. H., Kim, S. J., Kim, W. S., Chung, D. R., Kang, C., Peck, K. R., & Jung, C. W. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.06.011 · Cited by 56
Zhang, W., Song, X., Wu, H., & Zheng, R. (2019) · Epidemiology and Infection · doi:10.1017/s0950268819001638 · Cited by 56
The role ofCandida albicansAP-1 protein against host derived ROS in in vivo models of infection
Jain, C. M., Pastor, K., Gonzalez, A. Y., Lorenz, M. C., & Rao, R. P. (2013) · Virulence · doi:10.4161/viru.22700 · Cited by 56
Lohse, M. B., & Johnson, A. D. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.115.024885 · Cited by 55
Chitty, S. A., Mobbs, S., Rifkin, B. S., Stogner, S. W., Lewis, M. S., Betancourt, J., DellaVolpe, J. D., Abouzahr, F., Wilhelm, A. M., Szerlip, H. M., et al. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000662 · Cited by 55
Carvalho, G. G., Felipe, M. P., & Costa, M. S. (2009) · The Journal of Microbiology · doi:10.1007/s12275-009-0059-0 · Cited by 55
Seman, B. G., Moore, J. L., Scherer, A. K., Blair, B. A., Manandhar, S., Jones, J. M., & Wheeler, R. T. (2018) · Infection and Immunity · doi:10.1128/iai.00415-18 · Cited by 46
García, C., Burgain, A., Chaillot, J., Pic, É., Khemiri, I., & Sellam, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29973-8 · Cited by 54
Glasmacher, A. G., & Prentice, A. G. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki221 · Cited by 54
Chang, H., Tsai, P.-W., Huang, H.-H., Liu, Y.-S., Chien, T.-S., & Lan, C. (2011) · Biochemical Journal · doi:10.1042/bj20111454 · Cited by 53
UPC2A Is Required for High-Level Azole Antifungal Resistance in Candida glabrata
Whaley, S. G., Caudle, K. E., Vermitsky, J.-P., Chadwick, S. G., Toner, G., Barker, K. S., Gygax, S. E., & Rogers, P. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02217-13 · Cited by 52
Gonzales, F. P., Felgenträger, A., Bäumler, W., & Maisch, T. (2013) · Future Microbiology · doi:10.2217/fmb.13.44 · Cited by 52
Glöckner, A. (2011) · European journal of medical research · doi:10.1186/2047-783x-16-4-167 · Cited by 52
Candidemia on presentation to the hospital: development and validation of a risk score
Shorr, A. F., Tabak, Y. P., Johannes, R. S., Sun, X., Spalding, J., & Kollef, M. H. (2009) · Critical Care · doi:10.1186/cc8110 · Cited by 43
Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside
Hope, W. W., & Drusano, G. L. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02913.x · Cited by 52
Sheth, C. C., Hall, R. A., Lewis, L. E., Brown, A. J. P., Odds, F. C., Erwig, L. P., & Gow, N. A. R. (2011) · Medical Mycology · doi:10.3109/13693786.2010.551425 · Cited by 51
Appropriate Antibiotic Therapy
Allison, M. G., Heil, E. L., & Hayes, B. D. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.08.003 · Cited by 51
Uehara, Y., Yagoshi, M., Tanimichi, Y., Yamada, H., Shimoguchi, K., Yamamoto, S., Yanai, M., & Kumasaka, K. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp0h2dambxzuss · Cited by 51
Pu, S., Niu, S., Zhang, C., Xu, X., Qin, M., Huang, S., & Zhang, L. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2015.01.005 · Cited by 50
Development of a High-Throughput Candida albicans Biofilm Chip
Srinivasan, A., Uppuluri, P., Lopez-Ribot, J. L., & Ramasubramanian, A. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019036 · Cited by 50
Alkharashi, N., AlJohani, S. M., Layqah, L. A., Masuadi, E., Baharoon, W., Al-Jahdali, H. H., & Baharoon, S. A. (2019) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2019/2015692 · Cited by 50
Poissy, J., Sendid, B., Damiens, S., Ishibashi, K. I., François, N., Kauv, M., Favory, R., Mathieu, D., & Poulain, D. (2014) · Critical Care · doi:10.1186/cc13953 · Cited by 50
Wang, G., Sun, M., Fang, J., Yang, Q., Tong, H., & Wang, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.022 · Cited by 50
Epidemiology and Evolution of Fungal Pathogens in Plants and Animals
Gladieux, P., Byrnes, E. J., Aguileta, G., Fisher, M. C., Heitman, J., & Giraud, T. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384890-1.00004-2 · Cited by 50
Drew, R. H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.018 · Cited by 50
Emerging echinocandins for treatment of invasive fungal infections
Turner, M., Drew, R. H., & Perfect, J. R. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.2.231 · Cited by 50
Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship
Mellinghoff, S. C., Hartmann, P., Cornely, F. B., Knauth, L., Koehler, F. C., Köhler, P., Krause, C., Kronenberg, C., Kranz, S.-L., Menon, V. P., et al. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3285-8 · Cited by 49
O'Meara, T. R., & Cowen, L. E. (2014) · Cellular Microbiology · doi:10.1111/cmi.12266 · Cited by 48
Rapid Detection of Candida albicans by Polymerase Spiral Reaction Assay in Clinical Blood Samples
Jiang, X., Dong, D., Bian, L., Zou, D., He, X., Ao, D., Yang, Z., Huang, S., Liu, N., Liu, W., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00916 · Cited by 48
How to Identify Invasive Candidemia in ICU—A Narrative Review
Alves, J., Alonso-Tarrés, C., & Rello, J. (2022) · Antibiotics · doi:10.3390/antibiotics11121804 · Cited by 48
Acosta, J., Catalán, M., del Palacio‐Pérez‐Medel, Á., Montejo, J. C., de la Cruz, J., Moragues, M. D., Pontón, J., Finkelman, M., & del Palacio, A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1365-0 · Cited by 48
Wang, X., Chang, P., Ding, J., & Chen, J. (2013) · Eukaryotic Cell · doi:10.1128/ec.00275-12 · Cited by 48
Candida bloodstream infections in hemodialysis recipients
Pyrgos, V. J., Ratanavanich, K. M., Donegan, N., Veis, J. H., Walsh, T. J., & Shoham, S. (2008) · Medical Mycology · doi:10.1080/13693780802369332 · Cited by 48
Prophylaxis and treatment of invasive candidiasis in the intensive care setting
Ostrosky-Zeichner, L. L. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1215-4 · Cited by 48
Hirakawa, M. P., Chyou, D. E., Huang, D., Slan, A. R., & Bennett, R. J. (2017) · Genetics · doi:10.1534/genetics.117.300295 · Cited by 47
Harris, M. R., & Coote, P. J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.021 · Cited by 47
Ultrasensitive SERS platform made via femtosecond laser micromachining for biomedical applications
Szymborski, T. R., Stepanenko, Y., Niciński, K., Piecyk, P., Berus, S. M., Adamczyk-Popławska, M., & Kamińska, A. (2021) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2021.03.083 · Cited by 47
Martin‐Manso, G., Navarathna, D. H. M. L. P., Galli, S., Soto‐Pantoja, D. R., Kuznetsova, S. A., Tsokos, M., & Roberts, D. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048775 · Cited by 47
Metadata
- Authors
- Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D.
- Affiliations
- University of Iowa Hospitals and Clinics (US)
- University of Iowa (US)
- Corresponding author
- Diekema, D.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-11-01
- Volume
- 37
- Issue
- 9
- Pages
- 1172-1177
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2118236446
- Cited by
- 1,140
- References
- 37
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 22 · 2023: 30 · 2022: 35 · 2021: 34 · 2020: 35 · 2019: 38 · 2018: 35 · 2017: 51 · 2016: 41 · 2015: 59 · 2014: 74 · 2013: 76 · 2012: 60
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial candidemia, attributable mortality, candidemia, mortality, matched case-control comparison, underlying disease, risk factors, nosocomial infections
- MeSH terms
- Age Factors, Antifungal Agents, Candida, Candidiasis, Cross Infection, Female, Humans, Length of Stay, Male, Microbial Sensitivity Tests, Middle Aged, Retrospective Studies, Sex Factors, Cohort Studies, Fluconazole, Survival Rate, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.